13F

Stock

Crispr Therapeutics Ag

CRSP · held by 3 managers

Reported value

$22.3M

Holders

3

+1 new · −0 exited

Holders’ est. mark

$4.07M

Price effect on 2 books still in the name

Largest holder

$21M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC373.2K$21M$3.95MAdded$4.59M
Norris Financial Group, LLC12.1K$679KNew
Marex Group plc11.5K$646.6K$125.7KCut−$117.1K

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.